Lacosamide Solution
Product Images NDC 31722-627

This is the label of Lacosamide oral solution USP, with a strength of 10 mg/mL, manufactured for Camber Pharmaceuticals. It is indicated to treat partial-onset seizures and diabetic neuropathic pain. It requires a medication guide, so the pharmacist must provide it to each patient. The usual dosage must adhere to the package insert. It should be stored at 20° to 25°C (68° to 77°F), with excursions of between 15° to 30°C (59° to 86°F) permitted (see USP Controlled Room Temperature). It is forbidden to freeze the solution. After seven (7) weeks of opening, the bottle should be discarded if any of the product remains. The oral solution contains phenylalanine, which could be harmful to patients with phenylketonuria. Furthermore, it is manufactured by HETERO LABS LIMITED in Hyderabad, India.*

The text consists of information about a medication called Lacosamide Oral Solution which contains 10 mg of lacosamide per mL. The solution should be stored at room temperature and should not be frozen. The medication guide should be provided to patients by the pharmacist. Additionally, the bottle should be discarded after seven weeks of opening. The NDC number and the manufacturing license number of Camber Pharmaceuticals, Inc. are also provided. The text also contains a warning to phenylketonurics that a 200 mg dose of the oral solution contains 0.32 mg of phenylalanine. There may be some missing information due to errors.*

This is the description for Lacosamide Oral Solution, USP. Each mL contains 10 mg of Lacosamide, USP. A 200 mg dose of this medicine contains 0.32 mg of phenylalanine. See package insert for dosage information. Store between 20° to 25°C (68° to 77°F). Discard unused product after seven (7) weeks of first opening. Keep out of reach of children. Manufactured by Camber Pharmaceuticals and Hetero Labs Limited in India. A Medication Guide is available on the manufacturer's website. Contact the US number for more information.*